A detailed history of Key F Inancial Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Key F Inancial Inc holds 12 shares of PRTA stock, worth $184. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 12 -0.0%
Holding current value
$184
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$19.54 - $26.15 $234 - $313
12 New
12 $0
Q1 2021

Apr 30, 2021

SELL
$11.0 - $28.24 $264 - $677
-24 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$10.12 - $13.94 $242 - $334
24 New
24 $0
Q2 2020

Aug 07, 2020

SELL
$9.56 - $12.51 $229 - $300
-24 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$7.54 - $15.77 $180 - $378
24 New
24 $0

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $723M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.